Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,028.00
Market cap: ₹2,158 Cr
Revenue (annual): ₹904.1 Cr
Net profit (annual): ₹66.44 Cr
P/E (TTM): 32.5×Sector 47.4×
Promoter holding: 63.31%+1.41% QoQ
FII holding: 2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Earnings Call 4 Financial Results 3 Results Update 2 Management Change 2 Annual General Meeting 2 Other Announcement 1 Employee Stock Options 1 Dividend 1 Debt & Borrowing 1 Credit Rating 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 15:24 IST BSE

Financial Results

Windlas Biotech Q1 FY27 Results: Net Profit ₹17.7 Cr, Up 0.0% YoY

Windlas Biotech Ltd reported revenue from operations of ₹248.1 Cr (+18.1% YoY) and net profit of ₹17.7 Cr (+0.0% YoY) for Q1 FY27.

Key figure: Net profit ₹17.7 Cr · +0.0% YoY

Open full results → Read the filing ↗

21 May 2026 16:34 IST BSE

Financial Results

Windlas Biotech Q4 FY26 Results: Net Profit ₹16 Cr, Down 1.8% YoY

Windlas Biotech Ltd reported revenue from operations of ₹238.5 Cr (+17.7% YoY) and net profit of ₹16 Cr (-1.8% YoY) for Q4 FY26.

Key figure: Net profit ₹16 Cr · -1.8% YoY

Open full results → Read the filing ↗

21 May 2026 16:33 IST BSE

Financial Results

Windlas Biotech Financial Results

Windlas Biotech approved audited FY26 financial results and recommended a Rs. 6.30 per share dividend. The company reported unmodified audit opinions for both standalone and consolidated statements.

Value: ₹0.63 Cr

Read the filing ↗